These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3315898)

  • 21. [Apolipoprotein(a) phenotypes as markers of genetic susceptibility for cardiovascular risk in occupational medicine].
    Mennoia NV; Gazzaruso C; Geroldi D; Candura SM
    G Ital Med Lav Ergon; 1999; 21(3):206-17. PubMed ID: 10771732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Future genetic-epidemiological research in coronary heart disease: the decade of the apolipoproteins, dysapolipoproteinemia, and dyslipoproteinemia.
    Glueck CJ
    Prog Clin Biol Res; 1984; 147():525-32. PubMed ID: 6377319
    [No Abstract]   [Full Text] [Related]  

  • 23. Common genetic variants that relate to disorders of lipid transport in Spanish subjects with premature coronary artery disease.
    Masana L; Febrer G; Cavanna J; Baroni MG; Marz W; Hoffmann MM; Shine B; Galton DJ
    Clin Sci (Lond); 2001 Feb; 100(2):183-90. PubMed ID: 11171287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of lipid, apolipoprotein levels and apolipoprotein E genotype in young Italian patients with myocardial infarction.
    Scaglione L; Bergerone S; Gambino R; Imazio M; Macchia G; Cravetto A; Gaschino G; Baralis G; Rosettani E; Pagano G; Cassader M
    Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):118-24. PubMed ID: 10464784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein(a) phenotypes and their predictive value for coronary heart disease: identification of an operative cut-off of apolipoprotein(a) polymorphism.
    Gazzaruso C; Garzaniti A; Buscaglia P; Bonetti G; Falcone C; Fratino P; Finardi G; Geroldi D
    J Cardiovasc Risk; 1998 Feb; 5(1):37-42. PubMed ID: 9816554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CAD: maybe cholesterol isn't the culprit.
    Zoler ML
    Geriatrics; 1984 Sep; 39(9):113, 117, 120. PubMed ID: 6468933
    [No Abstract]   [Full Text] [Related]  

  • 27. [Apolipoproteins: valuable indicators of atherogenicity in patients with coronary disease and normal blood lipids].
    Mordasini R; Riesen W
    Ann Med Interne (Paris); 1983; 134(5):479-82. PubMed ID: 6418049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Letter to the editor.
    Baum L
    Metabolism; 2006 Feb; 55(2):277; author reply 277. PubMed ID: 16423638
    [No Abstract]   [Full Text] [Related]  

  • 29. [Apolipoproteins B and A-I in the plasma of a random sample of an organized population of 20 to 59-year-old men and ischemic heart disease].
    Dobordzhginidze LM; Perova NV; Khaltaev NG; Metel'skaia VA; Grishenkov EA
    Ter Arkh; 1987; 59(1):22-6. PubMed ID: 3563908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lipid and apolipoprotein levels in health and disease].
    Steinerová A; Stozický F; Dudek J; Novák J; Polívková V; Topolcan O; Karlícek V
    Vnitr Lek; 1987 Feb; 33(2):105-12. PubMed ID: 3824933
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of apolipoprotein E gene plasma levels of lipids, lipoproteins, apolipoproteins and its relation with coronary heart disease].
    Zhu T; Wang Z; Zhao S
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):149-51. PubMed ID: 10681829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The low down on lipoprotein lipase.
    Funke H; Assmann G
    Nat Genet; 1995 May; 10(1):6-7. PubMed ID: 7647792
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum HDL-cholesterol, apo-A-I and apo-E levels in patients with abnormal coronary arteries.
    Tan MH; Weldon KL; Albers JJ; Cheung MC; Havel RJ; Vigne JL
    Clin Invest Med; 1980; 3(3-4):225-32. PubMed ID: 6784991
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of lipid and lipoprotein profiles in risk assessment and therapy.
    Ballantyne CM; Hoogeveen RC
    Am Heart J; 2003 Aug; 146(2):227-33. PubMed ID: 12891189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dyslipidemias and coronary disease].
    Douste-Blazy P; Douste-Blazy L
    Ann Biol Clin (Paris); 1986; 44(5):559-64. PubMed ID: 3544979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic research in coronary heart disease.
    Motulsky AG
    Prog Clin Biol Res; 1984; 147():541-8. PubMed ID: 6330756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Apolipoproteins and screening for coronary atherosclerosis].
    Cano Y; Malandain H
    Presse Med; 1983 Apr; 12(19):1236. PubMed ID: 6221307
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiovascular disease and hyperlipidaemia.
    Krauss RM; Kesäniemi YA
    Curr Opin Lipidol; 1994 Aug; 5(4):249-51. PubMed ID: 7981954
    [No Abstract]   [Full Text] [Related]  

  • 39. Apolipoproteins: pathophysiology and clinical implications.
    Patsch W; Gotto AM
    Methods Enzymol; 1996; 263():3-32. PubMed ID: 8748998
    [No Abstract]   [Full Text] [Related]  

  • 40. Apoprotein measurements.
    Albers JJ
    Adv Exp Med Biol; 1985; 183():125-33. PubMed ID: 4036698
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.